Association of MDR1 , CYP2D6 , and CYP2C19 gene polymorphisms with prophylactic migraine treatment response-Reference-Cited by-同舟云学术

Association of MDR1 , CYP2D6 , and CYP2C19 gene polymorphisms with prophylactic migraine treatment response

Published:2016-07 Issue: Volume:366 Page:149-154
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Atasayar Gulfer,Eryilmaz Isil Ezgi,Karli Necdet,Egeli Unal,Zarifoglu Mehmet,Cecener Gulsah,Taskapilioglu Ozlem,Tunca Berrin,Yildirim Oznur,Ak Secil,Tezcan Gulcin,Can Fatma Ezgi

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference27 articles.

1. Headache in Clinical Practise;Silberstein,2002

2. Preventive migraine treatment;Silberstein;Neurol. Clin.,2009

3. Update on the prophylaxis of migraine;Schurks;Curr. Treat. Options Neurol.,2008

4. EFNS guideline on the drug treatment of migraine-report of an EFNS task force;Evers;Eur. J. Neurol.,2006

5. Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations;Loder;Headache,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of genetic factors on the response to migraine therapy;Reviews in the Neurosciences;2024-06-11

2. Pharmacogenetics in Primary Headache Disorders;Frontiers in Pharmacology;2022-02-10

3. The effect of gender differences on the use of valproic acid for migraine prophylaxis;Journal of Health Sciences and Medicine;2021-07-15

4. A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine;Journal of Molecular Neuroscience;2021-01-14

5. Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin;Current Pharmaceutical Design;2019-11-19